FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2018403460> ?p ?o ?g. }

• W2018403460 endingPage "696" @default.
• W2018403460 startingPage "686" @default.
• W2018403460 abstract "Chronic allograft nephropathy is an important cause of graft failure. Many donor and recipient factors contribute to its development. Prospective analysis of these factors has been hindered by the lack of sensitive and specific indicators of renal injury. As a consequence protocol biopsies have been increasingly used in the assessment of renal allograft injury. We performed protocol renal allograft biopsies to prospectively examine the role of important determinants and mediators of chronic allograft nephropathy.A total of 51 consecutive cadaveric renal transplant recipients entered a randomized prospective study of tacrolimus (Tac) versus cyclosporine (CsA) microemulsion based immunosuppression. Study patients underwent protocol renal allograft biopsies at the time of engraftment and at 3, 6 and 12 months post-transplantation. Biopsies were analyzed by quantitative polymerase chain reaction (PCR) for mRNA for transforming growth factor-beta (TGF-beta), thrombospondin, and fibronectin. Measurements of renal structural injury were estimated by quantitative assessment of interstitial fibrosis and glomerulosclerosis. Changes in profibrotic growth factors and renal structural injury were related to donor and recipient determinants by stepwise regression analysis.Longitudinal assessment of renal injury demonstrated an early and progressive increase in mRNA for TGF-beta, thrombospondin (TSP) and fibronectin (FBN): TGF-beta baseline, 1.9 +/- 0.2 log copies; TGF-beta 6 months, 2.5 +/- 0.2 log copies, P < 0.05 6 months vs. baseline; TSP baseline, 1.9 +/- 0.2 log copies; TSP 6 months, 2.4 +/- 0.2 log copies, P < 0.05 6 months vs. baseline; FBN baseline, 2.0 +/- 0.2 log copies; FBN 12 months, 2.3 +/- 0.2 log copies, P < 0.05 12 months vs. baseline. This increase in profibrotic growth factors within the allograft was associated with a significant increase in interstitial fibrosis (Vvi) on renal biopsies: Vvi baseline, 13 +/- 1%; Vvi 3 months, 18 +/- 1%; Vvi 6 months, 28 +/- 2%; Vvi 12 months, 34 +/- 2%; P < 0.05 3, 6, and 12 months vs. baseline. Histological analysis demonstrated chronic allograft nephropathy in 4% biopsies at 3 months, 12% at 6 months and in 49% at 12 months. These changes in renal structure were not associated with any change in creatinine clearance (CCr): CCr 3 months, 56 +/- 2 mL/min, CCr 24 months, 56 +/- 2 mL/min; P=NS. Stepwise regression analysis of key donor and recipient determinants of chronic renal injury identified calcineurin inhibitors and acute rejection episodes as important factors involved in the development of chronic renal injury. In particular, the use of cyclosporine compared to tacrolimus was associated with a tenfold increase in TGF-beta mRNA (TGF-beta mRNA at 6 months, CsA vs. Tac, 3 +/- 0.3 vs. 2 +/- 0.3 log copies, P < 0.05), interstitial fibrosis (Vvi at 6 months, CsA vs. Tac, 33 +/- 4% vs. 24 +/- 2%, P < 0.05). Changes in growth factors and renal structure predicted impaired renal function (CCr at 12 months, CsA vs. Tac, 53 +/- 4 mL/min vs. 62 +/- 2 mL/min, P < 0.05). Similarly, acute rejection episodes were associated with an accelerated development of interstitial fibrosis (Vvi at 6 months, acute rejection vs. no rejection, 34 +/- 3% vs. 25 +/- 2%; P < 0.05), but not with changes in TGF-beta, thrombospondin or fibronectin expression.Our results suggest that structural injury develops early in the natural history of the renal allograft and is mediated, in part, by the early up-regulation of profibrotic growth factors. We have determined that calcineurin inhibitors, in particular cyclosporine, and acute rejection episodes are key factors in the development of renal structural injury." @default.
• W2018403460 created "2016-06-24" @default.
• W2018403460 creator A5025559307 @default.
• W2018403460 creator A5029416858 @default.
• W2018403460 creator A5034380341 @default.
• W2018403460 creator A5061986158 @default.
• W2018403460 creator A5089155442 @default.
• W2018403460 date "2002-02-01" @default.
• W2018403460 modified "2023-10-18" @default.
• W2018403460 title "Molecular and structural consequences of early renal allograft injury" @default.
• W2018403460 cites W1191988858 @default.
• W2018403460 cites W1550111394 @default.
• W2018403460 cites W1900562057 @default.
• W2018403460 cites W1932268205 @default.
• W2018403460 cites W1969374130 @default.
• W2018403460 cites W1987651365 @default.
• W2018403460 cites W1993606933 @default.
• W2018403460 cites W1995791071 @default.
• W2018403460 cites W1998990953 @default.
• W2018403460 cites W1999189582 @default.
• W2018403460 cites W2003964387 @default.
• W2018403460 cites W2011795159 @default.
• W2018403460 cites W2015795623 @default.
• W2018403460 cites W2016710177 @default.
• W2018403460 cites W2022665089 @default.
• W2018403460 cites W2036789134 @default.
• W2018403460 cites W2037876399 @default.
• W2018403460 cites W2039479909 @default.
• W2018403460 cites W2048693715 @default.
• W2018403460 cites W2053352199 @default.
• W2018403460 cites W2056338262 @default.
• W2018403460 cites W2059727397 @default.
• W2018403460 cites W2071342972 @default.
• W2018403460 cites W2073601215 @default.
• W2018403460 cites W2084462182 @default.
• W2018403460 cites W2087749727 @default.
• W2018403460 cites W2091754751 @default.
• W2018403460 cites W2093603781 @default.
• W2018403460 cites W2102526131 @default.
• W2018403460 cites W2106037323 @default.
• W2018403460 cites W2121454052 @default.
• W2018403460 cites W2136645517 @default.
• W2018403460 cites W2154365158 @default.
• W2018403460 cites W2156608992 @default.
• W2018403460 cites W2248952102 @default.
• W2018403460 cites W2324375367 @default.
• W2018403460 cites W2329414459 @default.
• W2018403460 cites W2333378480 @default.
• W2018403460 cites W2342967759 @default.
• W2018403460 cites W2464998030 @default.
• W2018403460 cites W4245114305 @default.
• W2018403460 cites W4301865142 @default.
• W2018403460 doi "https://doi.org/10.1046/j.1523-1755.2002.00149.x" @default.
• W2018403460 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11849412" @default.
• W2018403460 hasPublicationYear "2002" @default.
• W2018403460 type Work @default.
• W2018403460 sameAs 2018403460 @default.
• W2018403460 citedByCount "118" @default.
• W2018403460 countsByYear W20184034602012 @default.
• W2018403460 countsByYear W20184034602013 @default.
• W2018403460 countsByYear W20184034602014 @default.
• W2018403460 countsByYear W20184034602015 @default.
• W2018403460 countsByYear W20184034602016 @default.
• W2018403460 countsByYear W20184034602017 @default.
• W2018403460 countsByYear W20184034602018 @default.
• W2018403460 countsByYear W20184034602019 @default.
• W2018403460 countsByYear W20184034602020 @default.
• W2018403460 countsByYear W20184034602021 @default.
• W2018403460 countsByYear W20184034602022 @default.
• W2018403460 crossrefType "journal-article" @default.
• W2018403460 hasAuthorship W2018403460A5025559307 @default.
• W2018403460 hasAuthorship W2018403460A5029416858 @default.
• W2018403460 hasAuthorship W2018403460A5034380341 @default.
• W2018403460 hasAuthorship W2018403460A5061986158 @default.
• W2018403460 hasAuthorship W2018403460A5089155442 @default.
• W2018403460 hasBestOaLocation W20184034601 @default.
• W2018403460 hasConcept C126322002 @default.
• W2018403460 hasConcept C126894567 @default.
• W2018403460 hasConcept C134018914 @default.
• W2018403460 hasConcept C2777390665 @default.
• W2018403460 hasConcept C2779458710 @default.
• W2018403460 hasConcept C2779561371 @default.
• W2018403460 hasConcept C2780091579 @default.
• W2018403460 hasConcept C2780252810 @default.
• W2018403460 hasConcept C2780303639 @default.
• W2018403460 hasConcept C2781184683 @default.
• W2018403460 hasConcept C2911091166 @default.
• W2018403460 hasConcept C555293320 @default.
• W2018403460 hasConcept C71924100 @default.
• W2018403460 hasConcept C90924648 @default.
• W2018403460 hasConceptScore W2018403460C126322002 @default.
• W2018403460 hasConceptScore W2018403460C126894567 @default.
• W2018403460 hasConceptScore W2018403460C134018914 @default.
• W2018403460 hasConceptScore W2018403460C2777390665 @default.
• W2018403460 hasConceptScore W2018403460C2779458710 @default.
• W2018403460 hasConceptScore W2018403460C2779561371 @default.
• W2018403460 hasConceptScore W2018403460C2780091579 @default.
• W2018403460 hasConceptScore W2018403460C2780252810 @default.

• next